Back
Akero Therapeutics Stock Predictions
![](/images/offers/ims/large/offer8.jpg)
Recent Tech Boom Could Send "EarnPhone" Soaring
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
69
AKRO
Akero Therapeutics
Last Price:
$49.43
Seasonality Move:
-13.61%
7 Day Trial
ALL ACCESS PASS
$
7
![](/images/offers/ims/large/offer13.jpg)
Data Just Made Palantir Worth $200B - Is This #1 Software Company Next?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Akero Therapeutics Stock Forecast
-
Over the next 52 weeks, Akero Therapeutics has on average historically risen by 54.7% based on the past 5 years of stock performance.
-
Akero Therapeutics has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
-
Is Akero Therapeutics Stock Undervalued?The current Akero Therapeutics [AKRO] share price is $49.95. The Score for AKRO is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
-
AKRO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will Akero Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Akero Therapeutics has on average historically risen by 54.7% based on the past 5 years of stock performance.
Akero Therapeutics Stock Rating
Buy
69
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics overpriced?
-
Akero Therapeutics has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
Akero Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
akerotx.com
52-Week Data
52-Week High:
58.40
52-Week Low:
17.86
Prediction Charts
Market Cap:
3.5B
Price in USD:
49.95
Volume:
1.4M
Beta:
-0.15
Technical Analysis
SMA50:
34.20
SMA100:
32.13
SMA200:
27.85
52-Wk Change:
152.78%
Stock Predictions
-
Is Akero Therapeutics stock public?Yes, Akero Therapeutics is a publicly traded company.
-
What is the Akero Therapeutics stock quote today?The Akero Therapeutics stock price is 49.95 USD today.
-
How to buy Akero Therapeutics stock online?You can buy Akero Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Jan-23 | 24.77 | 26.16 | 26.23 | 24.69 |
Jan-24 | 26.11 | 26.18 | 26.47 | 25.69 |
Jan-27 | 57.26 | 51.71 | 58.40 | 48.47 |
Jan-28 | 54.63 | 51.47 | 57.48 | 49.38 |
Jan-29 | 52.48 | 54.00 | 55.74 | 51.79 |
Jan-30 | 55.74 | 55.36 | 57.51 | 54.66 |
Jan-31 | 54.82 | 54.08 | 55.88 | 52.89 |
Feb-3 | 53.77 | 53.85 | 54.69 | 52.63 |
Feb-4 | 53.60 | 56.41 | 57.25 | 53.60 |
Feb-5 | 56.87 | 57.56 | 57.66 | 55.60 |
Feb-6 | 57.12 | 54.95 | 57.78 | 54.32 |
Feb-7 | 54.81 | 54.21 | 55.32 | 53.88 |
Feb-10 | 55.81 | 51.15 | 55.81 | 51.06 |
Feb-11 | 50.51 | 49.95 | 51.13 | 48.90 |
Akero Therapeutics Earnings
Akero Therapeutics Earnings Report: Per Share Akero Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Akero Therapeutics Forecast Revenue Growth
Akero Therapeutics Stock Analysis: Historical quarterly revenues per share for Akero Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.89 per share, and a decrease next year of $0.10 per share.
* Akero Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.